Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,165,689
-
Share change
-
+806,650
-
Total reported value
-
$366,434,236
-
Price per share
-
$13.01
-
Number of holders
-
39
-
Value change
-
+$10,694,617
-
Number of buys
-
26
-
Number of sells
-
7
Institutional Holders of EVELO BIOSCIENCES INC - COM (EVLO) as of Q4 2018
As of 31 Dec 2018,
EVELO BIOSCIENCES INC - COM (EVLO) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,165,689 shares.
The largest 10 holders included
Flagship Pioneering Inc., FMR LLC, HarbourVest Partners LLC, CREDIT SUISSE AG/, Alphabet Inc., BlackRock Inc., Sectoral Asset Management Inc, Vanguard Group Inc, GOLDMAN SACHS GROUP INC, and Samsara BioCapital, LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.